Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety
UF startup Cannabix Technologies Inc., developer of the Cannabix Marijuana Breathalyzer devices for law enforcement and the workplace, reports that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for its 2015 licensed patent application, No. 14/689434 entitled, “Cannabis Drug Detection Device”.
The company and its patent attorneys have been vigorously pursuing this original patent application since its filing in the spring of 2015. It should be noted that a notice of allowance from the USPTO does not constitute a grant of patent. Cannabix Technologies will report on future material developments regarding its “Cannabis Drug Detection Device” patent application in due course.
Cannabix Technologies is on the forefront in research and development to create point-of-care breath testing technologies for the detection of ∆9-tetrahydrocannabinol (“THC”) – the psychoactive component of marijuana that causes impairment.Read more about Cannabix Technologies Receives Notice of Allowance for Cannabis Drug Detection Device U.S. Patent.